Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 1,102 | 1,211 | 1,448 | 1,221 | 1,443 |
| Operating Income | -1,102 | -1,211 | -1,448 | -1,221 | -1,443 |
| Interest Expense | 463 | 410 | 405 | 387 | 378 |
| Other Income | 1 | 6 | 26 | 52 | 0 |
| Pre-tax Income | -1,564 | -1,615 | -1,827 | -1,555 | -1,820 |
| Net Income Continuous | -1,564 | -1,615 | -1,827 | -1,555 | -1,820 |
| Net Income | $-1,564 | $-1,615 | $-1,827 | $-1,555 | $-1,820 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EBITDA(a) | $-1,099 | $-1,147 | $-1,277 | $-1,103 | $-1,254 |